• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bayer Ag S/Adr (OP:BAYRY)

    11.01 +0.04 (+0.36%)
    Streaming Delayed Price Updated: 3:59 PM EST, Mar 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Bayer Ag S/Adr

    < Previous 1 2 3 4 5 6 7 8 Next >
    News headline image
    Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades' ↗
    On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Nasdaq, Inc. (NASDAQ: NDAQ) is 
    Via Benzinga
    News headline image
    Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists ↗
    Unlock AI-powered radiology solutions with Bayer AG and Google Cloud collaboration. Accelerate medical imaging innovations with gen AI tools for faster diagnoses. 
    Via Benzinga
    Topics Artificial Intelligence
    News headline image
    Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds ↗
    Corporate bonds offer yield opportunities and diversification away from equity investments. Investment-grade bonds are safer but lower yield, while high-yield bonds offer higher returns but from... 
    Via Benzinga
    Topics Bonds
    News headline image
    Bayer-Backed Boundless Bio Falls After IPO ↗
    Shares of Boundless Bio fell almost 10% after raising about $100 million in the company's initial public offering. Bayer is one of the biggest investors for the therapeutics company. 
    Via Talk Markets
    Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
    Via AB Newswire
    Topics Supply Chain
    News headline image
    Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant ↗
    Bayer's Phase 3 study OASIS 3 findings on elinzanetant, a promising non-hormonal treatment for menopausal hot flashes. Results show significant reduction in symptoms over 12 weeks, marking a potential... 
    Via Benzinga
    News headline image
    German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits ↗
    Bayer contemplates Texas Two-Step bankruptcy to tackle Roundup lawsuits in the US amid mounting jury verdicts. Learn about the controversial tactic and its potential implications. 
    Via Benzinga
    Topics Bankruptcy Lawsuit
    News headline image
    BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q4 2023 ↗
    BAYRY stock results show that Bayer beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    News headline image
    Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges ↗
    Bayer charts strategic course amid structural evaluation. CEO Bill Anderson addresses group's challenges, prioritizing performance and flexibility. The company's focus and fiscal outlook for 2024. 
    Via Benzinga
    News headline image
    Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits ↗
    Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising. 
    Via InvestorPlace
    News headline image
    What's Going On With BridgeBio Pharma Stock On Monday? ↗
    BridgeBio Pharma partners with Bayer on acoramidis for ATTR-CM in Europe. $310 million deal, FDA application accepted. 
    Via Benzinga
    News headline image
    BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out? ↗
    BridgeBio will receive a tiered royalty on sales that begins at the low-30% range. 
    Via Investor's Business Daily
    News headline image
    Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? ↗
    On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks. 
    Via InvestorPlace
    News headline image
    3 Overextended Stocks That Need to Slash Their Dividends ASAP ↗
    The most common attribute of overextended stocks other than carrying too much debt is dividends that are too big. 
    Via InvestorPlace
    News headline image
    MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗
    MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months. 
    Via Talk Markets
    News headline image
    Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million ↗
    I-Mab will become a completely US-based company, divesting itself of I-Mab Biopharma (Hangzhou), an unconsolidated affiliate. I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China... 
    Via Talk Markets
    News headline image
    Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial ↗
    Follow the landmark Australian Roundup lawsuit against Bayer. Closing arguments in class action alleging Roundup's link to cancer. 
    Via Benzinga
    Topics Lawsuit
    News headline image
    Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout ↗
    "Bayer's Monsanto ordered to pay $2.2 billion in Roundup cancer case. Explore the landmark verdict, compensatory losses, and punitive damages. 
    Via Benzinga
    News headline image
    Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week ↗
    Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will... 
    Via Talk Markets
    News headline image
    Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance ↗
    Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the  
    Via Benzinga
    News headline image
    Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial ↗
    Monday, Bayer AG (OTC: BAYRY (OTC: BAYZF)  
    Via Benzinga
    News headline image
    Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial ↗
    Bayer completed an 18-month data collection in the Phase Ib trial for a gene therapy for treating patients with Parkinson's. 
    Via Benzinga
    News headline image
    Top Stocks, Sectors Loved By Congress Members Who Traded In 2023: Apple, NVIDIA, Microsoft, Ford And More Stocks To Watch In 2024 ↗
    One of the hottest topics among members of Congress and investors has been the stock and options trading activity by several politicians. 
    Via Benzinga
    News headline image
    Best 4 Agriculture Companies For Your 2024 Investment Portfolio ↗
    Agriculture is and remains, a crucial sector for sustaining life, offering investors diverse opportunities in this vital industry. 
    Via Talk Markets
    News headline image
    Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak ↗
    In a significant turn of events, Bayer AG (OTC: BAYRY) (OTC: BAYZF) emerged victorious in a California lawsuit filed by Bruce Jones, who alleged that the use of Roundup caused his non-Hodgkin... 
    Via Benzinga
    Topics Lawsuit
    News headline image
    ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US ↗
    With climate change becoming a mega market force, ESG investing is rising. The XVV is up 28% YTD. Agri-Tech stocks like Bayer AG, FMC Corporation, and Corteva Inc are providing climate resilience... 
    Via Benzinga
    Topics Climate Change
    News headline image
    AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗
    The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. 
    Via InvestorPlace
    Topics Artificial Intelligence
    News headline image
    Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss ↗
    Bayer AG (OTC: BAYRY) (OTC:  
    Via Benzinga
    News headline image
    Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion ↗
    The spotlight is on a Philadelphia trial as Bayer AG (OTC: BAYRY) (OTC: BAYZF) grapples with mounting legal challenges surrounding its Roundup weedkiller, prompted by multi-billion dollar verdicts  
    Via Benzinga
    Topics Lawsuit
    News headline image
    PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out ↗
    Big chemical companies won a lawsuit preventing 11.8 million Ohio residents from suing them for PFAS chemicals in their blood. 
    Via Benzinga
    Topics Lawsuit
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.